2 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
| Phase 2 | 2 | Withdrawn 2 |
Follow Vasculitis: new trials by email Literature Review of Vasculitis trials Research Report on Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders denosumab - Osteoporosis, Juvenile Rheumatoid Arthritis | Phase 1 / Phase 2 | Withdrawn | Indiana University | 2019-08-01 | 2019-12-06 | |
| A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease XOMA 052 - Muckle Wells Syndrome, Autoinflammatory | Phase 1 / Phase 2 | Withdrawn | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2010-08-27 | 2017-07-02 |
Arthritis (1) · Arthritis, Juvenile (1) · Behcet Syndrome (1) · Cryopyrin-Associated Periodic Syndromes (1) · Dermatomyositis (1) · Osteoporosis (1)
Cardiovascular Diseases (2) · Immune System Diseases (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Vascular Diseases (2) · Autoimmune Diseases (1) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Chronic Disease (1) · Chronic Inducible Urticaria (1) · Chronic Urticaria (1) · Cold Urticaria (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Disease Attributes (1)
Denosumab (1) · gevokizumab (1)
Indiana University (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)
United States (2)
Erik Imel, MD (1)